Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Inhibitor for HIF-1alpha relevant to non-small cell lung cancer radiotherapy

A non-small cell lung cancer, HIF-1 technology, applied in the field of medical drugs, can solve the problems of reduced curative effect of radiotherapy, unclear miRNA-21, increased expression level, etc., and achieve the effect of improving curative effect

Inactive Publication Date: 2016-06-29
SHANDONG TUMOR HOSPITAL
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Studies have shown that the increase in the expression level of HIF-1α can lead to a decrease in the efficacy of radiotherapy, but some literatures believe that HIF-1α does not affect the radiosensitivity of tumor cells
[0006] Although there are many reports on the radiosensitization of lung cancer cells, how miRNA-21 is controlled in radiotherapy-resistant non-small cell lung cancer cells is still unclear.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibitor for HIF-1alpha relevant to non-small cell lung cancer radiotherapy
  • Inhibitor for HIF-1alpha relevant to non-small cell lung cancer radiotherapy
  • Inhibitor for HIF-1alpha relevant to non-small cell lung cancer radiotherapy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] 1. Materials and methods

[0030] 1.1 Cell culture and radiotherapy treatment

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an inhibitor for HIF-1alpha relevant to non-small cell lung cancer radiotherapy, and discloses application of a miRNA-21 inhibitor in preparation of drugs for reducing the HIF-1alpha level in non-small cell lung cancer cells. The nucleotide sequence of the miRNA-21 is 5'-UAGCUUAUCAGACUGAUGUUGA-3' and is shown as SEQ ID NO.1. When the miRNA inhibitor is used, the content of HIF-1alpha which has radiotherapy resistance in the non-small cell lung cancer cells can be reduced, therefore, radiosensitivity of the non-small cell lung cancer cells can be improved, and the miRNA-21 inhibitor is more beneficial for the curative effect of radiotherapy of a non-small cell lung cancer.

Description

technical field [0001] The invention relates to the field of medical medicine, in particular to the application of a miRNA-21 inhibitor in the preparation of a medicine for reducing the level of HIF-1α in non-small cell lung cancer. Background technique [0002] miRNAs are functional non-coding RNAs, 20-24 nucleotides in length, that play an important role in controlling the stability and transcription efficiency of target miRNAs. The mature miRNA induces non-expression of the transcribed gene by including the complementary sequence of the target gene and including the 3' non-transcribed region. Therefore, the abnormal expression of miRNA may affect the transcription of target genes, and further affect the signaling pathways related to cancer, involving cell cycle regulation, apoptosis, mutation, migration and metabolism. Tumor tissues often show reduced amounts of functional miRNAs; however, miRNA-21 has been documented to play a role in carcinogenesis (oncomiR), and its h...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K48/00A61K45/00A61K31/7105A61P35/00
CPCA61K45/00A61K31/7105
Inventor 姜书梅王仁本司峻岭闫洪江窦雪
Owner SHANDONG TUMOR HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products